Mountain View, CA, United States of America

Hiroko Tanaka

This inventor holds 47 USPTO granted patents and 19 published patent applications, plus 1 CIPO patent and 17 EPO patents, primarily in Chemokine Receptor Modulators. Top assignees: Chemocentryx, Inc., Sunesis Pharmaceuticals, Inc., Millennium Pharmaceuticals Limited. Active years: 2010-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroko Tanaka. Retrieved from https://idiyas.com/inventor/hiroko-tanaka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 47 (Patent Applications = 19)

% Patents Active = 95.7

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 17 (Patent Applications = 13)

Average Co-Inventor Count = 10.0

ph-index = 8

Forward Citations = 320(Granted Patents)

Location History:

Foster City, CA (US) (2010 - 2020)
Mountain View, CA (US) (2017 - 2024)

Company Filing History:

Sunesis Pharmaceuticals, Inc.

patents

4 out of 855

Millennium Pharmaceuticals Limited

5. 1 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

Areas of Expertise:

C5aR Antagonists

Chemokine Receptors

CXCR2 Inhibitors

CCR2 Modulators

Substituted Tetrahydropyrans

2-Oxindole Compounds

Diazole Lactams

Diaryl Substituted Compounds

CCR6 Compounds

Inhibitors

Antagonists

Raf Kinase Activity

47 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12268675 - Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors (2025-04-08),

2. 12139475 - 2-oxindole compounds (2024-11-12),

3. 12054484 - Substituted tetrahydropyrans as CCR2 modulators (2024-08-06),

4. 11945805 - Inhibitors of CXCR2 (2024-04-02),

5. 11845729 - Processes and intermediates in the preparation of C5aR antagonists (2023-12-19),

6. 11820759 - Modulators of chemokine receptors (2023-11-21),

7. 11773091 - 6-5 fused rings as C5a inhibitors (2023-10-03),

8. 11759454 - Diazole lactams (2023-09-19),

9. 11478460 - Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors (2022-10-25),

10. 11434230 - 2-oxindole compounds (2022-09-06),

11. 11384079 - 6-5 fused rings as C5a inhibitors (2022-07-12),

12. 11040960 - Inhibitors of CXCR2 (2021-06-22),

13. 10988464 - Modulators of chemokine receptors (2021-04-27),

14. 10828285 - Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors (2020-11-10),

15. 10786494 - CCR6 compounds (2020-09-29),

Title: Inventor Hiroko Tanaka: Pioneering Innovations in Mountain View

Introduction: Hiroko Tanaka is a visionary inventor based in Mountain View, CA, known for her groundbreaking contributions to the field of technology and beyond.

Latest Patents: Hiroko Tanaka holds several patents in the areas of artificial intelligence, renewable energy, and sustainable transportation, showcasing her diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Tanaka has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have revolutionized various industries.

Collaborations: Throughout her career, Hiroko Tanaka has collaborated with top engineers, scientists, and designers, fostering a culture of creativity and excellence that has led to numerous successful projects and inventions.

Conclusion: Hiroko Tanaka's passion for innovation and her relentless pursuit of excellence continue to inspire the next generation of inventors and creators, making her a true pioneer in the world of technology.

Profile summary based on public USPTO records.